Entacapone’s therapeutic potential in renal fibrosis by targeting miR-34a/TGFβ1/Smad2 signaling: an experimental rat model study
Abstract Chronic kidney disorder is a rising danger to health that affects a significant percentage of older adults, and a crucial stage in its development is fibrosis. MicroRNAs and transforming_ growth factor-β1(TGF-β1) /SMAD2 signal pathway significantly regulate this process. miR-34a promotes ex...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-06-01
|
| Series: | Future Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43094-025-00829-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850100566152183808 |
|---|---|
| author | Yosra M. Magdy Sherif A. Kamar Tamer M. M. Abuamara Yomna M. Tamim Hayam Ateyya Marwa Tarek Nehal Samir Reham Hussein |
| author_facet | Yosra M. Magdy Sherif A. Kamar Tamer M. M. Abuamara Yomna M. Tamim Hayam Ateyya Marwa Tarek Nehal Samir Reham Hussein |
| author_sort | Yosra M. Magdy |
| collection | DOAJ |
| description | Abstract Chronic kidney disorder is a rising danger to health that affects a significant percentage of older adults, and a crucial stage in its development is fibrosis. MicroRNAs and transforming_ growth factor-β1(TGF-β1) /SMAD2 signal pathway significantly regulate this process. miR-34a promotes extracellular matrix (ECM) deposition and inhibits B cell lymphoma-2 (Bcl-2), a target gene with antifibrotic properties shown to protect against renal fibrosis in animal models. Currently, several drugs, including entacapone, have been reported to suppress miR-34a activation. Experimental model of Carbon- tetrachloride (CCl4)-induced renal fibrosis revealed elevated serum levels of urea and creatinine, an increased urinary microalbumin-to-creatinine ratio, deterioration of the antioxidant-oxidant balance, an increase in TGF-β1 in renal tissue, and increased renal miR–34a–SMAD2 expression were observed, accompanied by decreased expression of Bcl-2. Entacapone holds reno-protective promises likely via its anti-inflammatory-antioxidant effects in CCl4-induced renal fibrosis by favorable modulation of miR-34a /TGF-β1/SMAD2 Signaling Pathway. |
| format | Article |
| id | doaj-art-ddbbb13a15ed400b9db8656f1206e11c |
| institution | DOAJ |
| issn | 2314-7253 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Future Journal of Pharmaceutical Sciences |
| spelling | doaj-art-ddbbb13a15ed400b9db8656f1206e11c2025-08-20T02:40:15ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72532025-06-0111111310.1186/s43094-025-00829-zEntacapone’s therapeutic potential in renal fibrosis by targeting miR-34a/TGFβ1/Smad2 signaling: an experimental rat model studyYosra M. Magdy0Sherif A. Kamar1Tamer M. M. Abuamara2Yomna M. Tamim3Hayam Ateyya4Marwa Tarek5Nehal Samir6Reham Hussein7Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams UniversityDepartment of Basic Medical Sciences, Faculty of Dentistry, Al-Ahliyya Amman University (AAU)Department of Basic Medical Sciences, Faculty of Dentistry, Al-Ahliyya Amman University (AAU)Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams UniversityDepartment of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Future University in EgyptDepartment of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams UniversityDepartment of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams UniversityDepartment of Clinical Pharmacology, Faculty of Medicine, Ain Shams UniversityAbstract Chronic kidney disorder is a rising danger to health that affects a significant percentage of older adults, and a crucial stage in its development is fibrosis. MicroRNAs and transforming_ growth factor-β1(TGF-β1) /SMAD2 signal pathway significantly regulate this process. miR-34a promotes extracellular matrix (ECM) deposition and inhibits B cell lymphoma-2 (Bcl-2), a target gene with antifibrotic properties shown to protect against renal fibrosis in animal models. Currently, several drugs, including entacapone, have been reported to suppress miR-34a activation. Experimental model of Carbon- tetrachloride (CCl4)-induced renal fibrosis revealed elevated serum levels of urea and creatinine, an increased urinary microalbumin-to-creatinine ratio, deterioration of the antioxidant-oxidant balance, an increase in TGF-β1 in renal tissue, and increased renal miR–34a–SMAD2 expression were observed, accompanied by decreased expression of Bcl-2. Entacapone holds reno-protective promises likely via its anti-inflammatory-antioxidant effects in CCl4-induced renal fibrosis by favorable modulation of miR-34a /TGF-β1/SMAD2 Signaling Pathway.https://doi.org/10.1186/s43094-025-00829-zBcl-2CCl4EntacaponemiR-34aOxidative stressRenal fibrosis |
| spellingShingle | Yosra M. Magdy Sherif A. Kamar Tamer M. M. Abuamara Yomna M. Tamim Hayam Ateyya Marwa Tarek Nehal Samir Reham Hussein Entacapone’s therapeutic potential in renal fibrosis by targeting miR-34a/TGFβ1/Smad2 signaling: an experimental rat model study Future Journal of Pharmaceutical Sciences Bcl-2 CCl4 Entacapone miR-34a Oxidative stress Renal fibrosis |
| title | Entacapone’s therapeutic potential in renal fibrosis by targeting miR-34a/TGFβ1/Smad2 signaling: an experimental rat model study |
| title_full | Entacapone’s therapeutic potential in renal fibrosis by targeting miR-34a/TGFβ1/Smad2 signaling: an experimental rat model study |
| title_fullStr | Entacapone’s therapeutic potential in renal fibrosis by targeting miR-34a/TGFβ1/Smad2 signaling: an experimental rat model study |
| title_full_unstemmed | Entacapone’s therapeutic potential in renal fibrosis by targeting miR-34a/TGFβ1/Smad2 signaling: an experimental rat model study |
| title_short | Entacapone’s therapeutic potential in renal fibrosis by targeting miR-34a/TGFβ1/Smad2 signaling: an experimental rat model study |
| title_sort | entacapone s therapeutic potential in renal fibrosis by targeting mir 34a tgfβ1 smad2 signaling an experimental rat model study |
| topic | Bcl-2 CCl4 Entacapone miR-34a Oxidative stress Renal fibrosis |
| url | https://doi.org/10.1186/s43094-025-00829-z |
| work_keys_str_mv | AT yosrammagdy entacaponestherapeuticpotentialinrenalfibrosisbytargetingmir34atgfb1smad2signalinganexperimentalratmodelstudy AT sherifakamar entacaponestherapeuticpotentialinrenalfibrosisbytargetingmir34atgfb1smad2signalinganexperimentalratmodelstudy AT tamermmabuamara entacaponestherapeuticpotentialinrenalfibrosisbytargetingmir34atgfb1smad2signalinganexperimentalratmodelstudy AT yomnamtamim entacaponestherapeuticpotentialinrenalfibrosisbytargetingmir34atgfb1smad2signalinganexperimentalratmodelstudy AT hayamateyya entacaponestherapeuticpotentialinrenalfibrosisbytargetingmir34atgfb1smad2signalinganexperimentalratmodelstudy AT marwatarek entacaponestherapeuticpotentialinrenalfibrosisbytargetingmir34atgfb1smad2signalinganexperimentalratmodelstudy AT nehalsamir entacaponestherapeuticpotentialinrenalfibrosisbytargetingmir34atgfb1smad2signalinganexperimentalratmodelstudy AT rehamhussein entacaponestherapeuticpotentialinrenalfibrosisbytargetingmir34atgfb1smad2signalinganexperimentalratmodelstudy |